Author

Kevin Schwickert

ORCID 0000-0002-2575-0380Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Daniela BenderiD· 1 shared Eberhard HildtiD· 1 shared Kerstin K. SchwickertiD· 1 shared Mirco GlitscheriD· 1 shared Robin MurraiD· 1 shared Steffen Pfalzgraf· 1 shared Tanja SchirmeisteriD· 1 shared Ute A. HellmichiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Daniela BenderORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Late stages of the Zika virus life cycle are impaired by a selective TRPML2 agonist

Kerstin K. Schwickert, Mirco Glitscher, Daniela Bender, Robin Murra, Kevin Schwickert, Steffen Pfalzgraf, Tanja Schirmeister, Ute A. Hellmich, Eberhard Hildt

This study shows that the TRPML2 agonist ML2-SA1 inhibits late stages of Zika virus replication by affecting genome replication and intracellular cholesterol distribution.

bioRxiv · Feb 1, 2024 · PreprintCell Biology